首页> 外文期刊>Clinical and Translational Gastroenterology >A Novel Allergen-Specific Immune Signature-Directed Approach to Dietary Elimination in Eosinophilic Esophagitis
【24h】

A Novel Allergen-Specific Immune Signature-Directed Approach to Dietary Elimination in Eosinophilic Esophagitis

机译:一种新型的变应原特异性免疫信号定向方法,以消除嗜酸性粒细胞性食管炎的饮食

获取原文
       

摘要

OBJECTIVES:Dietary elimination for treatment of eosinophilic esophagitis (EoE) is limited by lack of accuracy in current allergy tests. We aimed to develop an immunologic approach to identify dietary triggers and prospectively test allergen-specific immune signature-guided dietary elimination therapy.METHODS:In the first phase, we developed and assessed 2 methods for determining selected food triggers using samples from 24 adults with EoE: a CD4+ T-cell proliferation assay in peripheral blood and food-specific tissue IgG4 levels in esophageal biopsies. In the second phase, we clinically tested elimination diets created from these methods in a prospective cohort treated for 6 weeks ({"type":"clinical-trial","attrs":{"text":"NCT02722148","term_id":"NCT02722148"}}NCT02722148). Outcomes included peak eosinophil counts (eos/hpf), endoscopic findings (measured by the EoE Endoscopic Reference Score), and symptoms (measured by the EoE Symptom Activity Index).RESULTS:Parameters were optimized with a positive test on either assay, yielding agreements of 60%, 75%, 53%, 58%, and 53% between predicted and known triggers of peanut, egg, soy, wheat, and milk, respectively. In clinical testing, the mean number of foods eliminated based on the assays was 3.4, and 19 of 22 subjects were compliant with treatment. After treatment, median peak eosinophil counts decreased from 75 to 35 (P = 0.007); there were 4 histologic responders (21%). The EoE Endoscopic Reference Score and EoE Symptom Activity Index score also decreased after treatment (4.6 vs 3.0; P = 0.002; and 32.5 vs 25.0; P = 0.06, respectively).DISCUSSION:We successfully developed a new testing approach using CD4+ T-cell proliferation and esophageal food-specific IgG4 levels, with promising accuracy rates. In clinical testing, this led to improvement in eosinophil counts, endoscopic severity, and symptoms of dysphagia, but a smaller than expected number of patients achieved histologic remission.
机译:目的:目前的过敏试验缺乏准确性,限制了通过饮食消除嗜酸性食管炎(EoE)。我们旨在开发一种免疫学方法来识别饮食触发因素,并前瞻性测试过敏原特异性免疫特征指导的饮食消除疗法。方法:在第一阶段,我们开发和评估了两种方法,使用来自24位EoE成人的样本来确定选定的食物触发因素:食管活检中外周血和食物特异性组织IgG4水平的CD4 + T细胞增殖测定。在第二阶段中,我们在为期6周的前瞻性队列中对通过这些方法创建的消除饮食进行了临床测试({“ type”:“ clinical-trial”,“ attrs”:{“ text”:“ NCT02722148”,“ term_id” :“” NCT02722148“}} NCT02722148)。结果包括嗜酸性粒细胞峰值计数(eos / hpf),内窥镜检查结果(通过EoE内窥镜参考评分测量)和症状(通过EoE症状活动指数测量)。分别在花生,鸡蛋,大豆,小麦和牛奶的预测触发因素和已知触发因素之间的比例分别为60%,75%,53%,58%和53%。在临床测试中,根据检测方法消除的平均食物数量为3.4,并且22位受试者中有19位符合治疗要求。治疗后,嗜酸性粒细胞峰值中位数从75降至35(P = 0.007);有4个组织学应答者(21%)。治疗后EoE内镜参考评分和EoE症状活动指数评分也分别下降(分别为4.6 vs 3.0; P = 0.002; 32.5 vs 25.0; P = 0.06)。讨论:我们成功开发了一种使用CD4 + T细胞的新检测方法增生和食管食物特异性IgG4的水平,准确率很高。在临床测试中,这可改善嗜酸性粒细胞计数,内窥镜检查的严重程度和吞咽困难症状,但组织学缓解的患者人数少于预期。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号